Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Zura Bio Ltd as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 95
- +2 vs. Q1 2026
- Shares held
- 72.9M
- +6.88M (+10.4%) vs. Q1 2026
- Total value
- $428.9M
- +$37.1M (+9.5%) vs. Q1 2026
- New holders
- 26
- 33 more added
- Sold out
- 24
- 18 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $428.9M |
| Q1 2026 | 94 | $391.8M |
| Q4 2025 | 75 | $235.1M |
| Q3 2025 | 69 | $179.2M |
| Q2 2025 | 65 | $37.1M |
| Q1 2025 | 74 | $59.0M |
| Q4 2024 | 87 | $107.2M |
| Q3 2024 | 78 | $151.1M |
| Q2 2024 | 57 | $114.9M |
| Q1 2024 | 45 | $37.6M |
| Q4 2023 | 44 | $70.7M |
| Q3 2023 | 41 | $93.3M |
| Q2 2023 | 38 | $105.0M |
| Q1 2023 | 3 | $24.7K |
| Q4 2022 | 35 | $87.4M |
| Q3 2022 | 33 | $84.2M |
| Q2 2022 | 36 | $77.7M |
| Q1 2022 | 34 | $58.1M |
| Q4 2021 | 25 | $48.5M |
| Q3 2021 | 17 | $31.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Zura Bio Ltd; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 0 | $0 | 0.00% | −278,890−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −95,355−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −84,865−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −77,505−100.0% | Sold out |
| Burkehill Global Management, LP | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −72,038−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −47,886−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −46,062−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −29,800−100.0% | Sold out |
| Brendel Financial Advisors LLC | 0 | $0 | 0.00% | −28,052−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −16,146−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −15,681−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −15,300−100.0% | Sold out |
| Mangrove Partners | 0 | $0 | 0.00% | −14,791−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |